Sexual Satisfaction and Distress in Sexual Functioning in a Sample of the BDSM Community: A Comparison Study Between BDSM and Non-BDSM Contexts

2015 ◽  
Vol 12 (4) ◽  
pp. 1052-1061 ◽  
Author(s):  
Patrícia Monteiro Pascoal ◽  
Daniel Cardoso ◽  
Rui Henriques
2019 ◽  
Vol 13 (11) ◽  
Author(s):  
Andrew J. Macnab ◽  
Lynn Stothers ◽  
Jonathan Berkowitz ◽  
Stacy Elliott ◽  
Francis Bajunirwe

Introduction: The recognized association between erectile dysfunction (ED) with lower urinary tract symptoms (LUTS) from high-income countries is unreported from Africa. Authentic figures on prevalence of ED and LUTS from Africa are scarce in the literature. This study was conducted to quantify sexual function and satisfaction among Ugandan men in relation to LUTS severity. Methods: A convenience sample of men participating in a parallel, cross-sectional survey was used. The population, men >55 years living in Sheema district, Uganda, were recruited into two cohorts: those living in the community and those seeking clinic care due to bother from LUTS. This was to ensure inclusion of a full spectrum of LUTS. The instruments were the International Prostate Symptom Score (IPSS) to quantify LUTS and the Epstein Inventory (EI) to assess four measures of sexual functioning. Bivariate analysis compared community and clinic cohort participants, LUTS severity, and each sexual functioning item with two-sample t-tests for means and Chi-square tests of independence for categorical versions. Results: Participants included 415 men (238 community and 177 clinic) at mean age of 67.5 years vs. 62.9 (p<0.001) with mean IPSS of 9.32 vs. 17.07 (p≤0.001). Lower mean satisfaction with sexual activity and frequency of erections occurred in the clinic cohort (p≤0.001). Overall, all four questions assessing dissatisfaction with sexual function were significantly correlated with worsening LUTS; sexual satisfaction and frequency of sexual drive were also influenced by age and low levels of education. Conclusions: These are the first data describing the severity relationship between LUTS and ED in African men. Respondents reported dissatisfaction in the past year with the level of their sexual activity, frequency of sexual drive, ability to have erections, and sexual performance that related statistically to the severity of their LUTS.


2011 ◽  
Vol 26 (S2) ◽  
pp. 1550-1550
Author(s):  
L. Mnif ◽  
J. Masmoudi ◽  
N. Charfi ◽  
I. Baati ◽  
M. Guermazi ◽  
...  

IntroductionThe sexual functioning problems in women after breast cancer are common. Certain factors related to treatment and its clinical implications may contribute to these problems.Objectives were to- Evaluate the changes in sexual life after treatment of breast cancer relative to the general population.- Identify the influence of demographic and clinical factors on sexuality.MethodsWe recruited 50 patients who were in remission for at least 3 months after initial treatment of breast cancer, and 50 healthy women.Sexuality and body image was evaluated using the Arabic version of the specific scale of breast cancer QLQ-BR23, which is an additional module to the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire.ResultsCompared with control subjects, patients reported more dyspareunia (61.5% vs 38.5%) and vaginal dryness (61.3% vs 38.7%). A diminished sense of sexual attractiveness was significantly more frequent within patients (p = 0.001).The patients had poor sexual functioning and sexual satisfaction and the mean scores were respectively 45.3% and 43.9%. Additional analyses indicated that menopausal status and sexual difficulties in the partner was significantly related to poorer sexual satisfaction (p respectively 0.018 and 0.014).The mean score of body image was 47.7% and its alteration had no significant impact on the themes of sexuality.ConclusionThese findings confirm and extend previous reports of impaired sexual functioning among breast cancer survivors. Results suggest that relief of sexual difficulties in partner should be an essential component of efforts to improve sexuality of patients.


2016 ◽  
Vol 9 (1) ◽  
pp. 158-158
Author(s):  
M. Gómez-Lugo ◽  
◽  
P. Vallejo-Medina ◽  
J. P. Saffón ◽  
D. Saavedra-Roa ◽  
...  

Objective: Sexual dysfunction is an important public health concern. Sexual dysfunctions, characterized by disturbances in sexual desire, arousal, erection, orgasm or sexual satisfaction have been reported in different research around the world. Prevalence range of disturbances is from 20% to 30% and 40% to 45% for men and women respectively. The aim of this study was to explore prevalence of sexual dysfunction in a Colombian male and female sample. Design and Method: Sample was composed by a non-representative national sample of 1366 women and 1410 men, aged from 18 to 73. To assess sexual dysfunction the Colombian version of the Massachusetts General Hospital- Sexual Functioning Questionnaire (MGH-SFQ) was used. Results: Results indicate on one hand that sexual dysfunction is more prevalent in women (42.5%) than men (32.1 %). On the other hand, in women, problems related to desire (28.5%) were more common, while in men those related to desire and sexual satisfaction, 21.4% and 21% respectively, were more prevalent. In women, problems related to desire (28.5%) were more common, while in men those related to desire and sexual satisfaction 21.4% and 21%, respectively were more prevalent. Furthermore, no evidence was found about the relationship between the sociodemographic characteristic (socioeconomic level, years of education and religion) and the sexual dysfunction; with exception of age. These results are similar to those observed in other cultures. Conclusions: This study shows the importance of epidemiologic research in male and female sexual dysfunction for the identification of risk factors.


Author(s):  
Maria Manuela Peixoto

Female sexual functioning and satisfaction are impaired by the presence of sexual difficulties. Current study aims to analyze the differences on sexual satisfaction in women according to types of sexual problems (absence of sexual problems, self-perceived and assessed by the FSFI cut-off). A total of 329 women answered to a specific question about presence of self-perceived sexual problems, the Sexual Satisfaction Scale for Women, and the Female Sexual Functioning Index. Main findings revealed that sexually health women had better levels of sexual satisfaction when compared to women who self-report sexual difficulties and women who scored clinical levels in FSFI. Also, women who scored clinical levels in FSFI scored lower on sexual satisfaction compared to women who self-report sexual difficulties. Female sexual satisfaction was negatively affected by sexual difficulties assessed according to the FSFI cut-off. Although with lower impact, self-perceived sexual problems also affect negatively sexual satisfaction in women.


2011 ◽  
Vol 26 (S2) ◽  
pp. 631-631
Author(s):  
R. Gismondi ◽  
A. Clayton ◽  
R. Baker ◽  
R. Forbes ◽  
S.V. Marler ◽  
...  

IntroductionThis presentation addresses impacts of adjunctive aripiprazole (AA) in major depressive disorder (MDD).ObjectiveAssess impacts of long-term (≤52 weeks) open-label AA to ADT on efficacy, sexual function and weight change in MDD.MethodsData were analyzed post-hoc from de novo patients enrolled in an open-label safety study of AA after inadequate response to one or more ADT. Three ADT classes were included: SSRIs, SNRIs, and a noradrenaline-dopamine reuptake inhibitor, bupropion.Global well-being with AA was assessed (mean change in CGI-S score from baseline by ADT). Sexual functioning was assessed by Sexual Function Inventory (SFI) items: interest in sex, sexual arousal, achievement of orgasm, erection maintenance and sexual satisfaction. Item 6 captured change in the overall improvement score. Weight change at Week 52 (last observation carried forward) was assessed.ResultsOverall mean change in CGI-S (n = 285) by Week 52 was -1.5. Mean changes in CGI-S from baseline scores (4.2-4.4) were: escitalopram (n=64) -1.5, venlafaxine XL (n = 48) -1.4, sertraline (n = 39) -1.7, fluoxetine (n = 41) -1.3, paroxetine or CR (n = 37) -1.5 and bupropion XL or SR (n = 46) -1.4. Improvements on SFI items (n = 155) ranged from -0.2 (sexual satisfaction) to -0.6 (interest in sex and orgasm). Mean overall improvement score (3.8) indicated mild-to-moderate sexual dysfunction. All AA groups experienced a mean weight increase (range +1.8 kg [sertraline] to +3.3 kg [fluoxetine]).ConclusionsAA moderately improved CGI-S scores (to a similar degree) when added to three different classes of ADTs. Sexual functioning in patients on ADT modestly improved after adding aripiprazole to ADT.


2017 ◽  
Vol 55 (9) ◽  
pp. 1155-1166 ◽  
Author(s):  
Patrícia M. Pascoal ◽  
E. Sandra Byers ◽  
Maria-João Alvarez ◽  
Pablo Santos-Iglesias ◽  
Pedro J. Nobre ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document